Harvard Bioscience Inc. (NSDQ:HBIO) added another company to its list of 20 subsidiaries.
The Holliston, Mass.-based life sciences instrument maker acquired Lehigh Valley, Pa.-based behavioral measurement product manufacturer Coulbourn Instruments.
Terms of the deal were not disclosed, but Harvard Bioscience said that the market for the devices Coulbourn develops is between $40 million and $50 million and expects the company to add about $4 million in annual revenues.
Coulbourn president Paul Mazzucco said in a prepared statement that his company’s "U.S. presence, manufacturing and distribution capabilities and Harvard’s behavioral product portfolio complement each other well."
